21st April 2021
Germany-based start-up, Clinomic, has announced successfully closing their latest funding round with a total of seven million euros.
Clinomic, which has been supported by various EIT Health activities, is developing a new solution to revolutionise patient care within intensive care units. As part of the solution, data from diagnostic devices are aggregated onto a single screen, while artificial intelligence is used to analyse the data and present healthcare professionals with support in decision making and efficient use of time and resources.
“The way intensive care is practised today can no longer continue. The burden on medical and nursing staff is high and the complexity continues to increase. Artificial intelligence algorithms can help us to rectify this situation. After all, doctors should have more time for their patients rather than having to spend it in front of screens,” said Arne Peine and Lukas Martin, Co-Founders of Clinomic, in a joint statement.
The team has been supported by EIT Health throughout their journey – gaining support on developing their business via the accelerator, and in developing the product itself as part of an EIT Health project which ran in 2019 and 2020.
Their latest funds will be utilised to further develop their solution to bring Clinomic closer to a reality of optimising the management of patients within intensive care.
EIT Health supports 17 promising deep tech start-ups bridge the ‘Valley of Death’
Providing start-ups with the right support.
EIT Health launches seven new members to its community
Enriching the EIT Health network with their collective expertise.
Driving personalised medicine forward
The second EP PerMed Round Table convened in Valencia and online.